MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/17085381221076320

Медицинская библиотека · Vascular · 2022

Mid-term outcomes of the use of endoanchors during thoracic endovascular aortic repair in multicentre analysis.

Reyes Valdivia Andrés, Milner Ross, Heijmen Robin, Riambau Vicente, Rousseau Hervé, Tinelli Giovanni, Kotelis Drosos, Zanabili Al-Sibbai Ahmad A, Pitoulias Georgios, Zúñiga Claudio Gandarias, de Beaufort Hector W L, Panagiotis Doukas, Chaudhuri Arindam

Многоцентровое исследованиеСтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

To describe mid-term outcomes of the use of EndoAnchors as an adjunct for arch and thoracic endovascular aortic repair (TEVAR).

METHODS

A retrospective multicentre series from nine centres using the Heli-FX EndoAnchor System (Medtronic Inc, Minneapolis, USA) at TEVAR over May 2014-May 2019 is presented. The study is registered at ClinicalTrials.gov with number NCT04100499. The primary outcome was freedom from Type I endoleak at EndoAnchors deployments; secondary outcomes included evaluation of aortic wall penetration (AWP) at first computed tomography scan, EndoAnchor-related issues and mortality.

RESULTS

54 high-risk patients (35 males/19 females, age 73 ± 11 years) with arch, thoracic and thoracoabdominal aneurysmal disease (3 chronic post-dissection and one patch pseudoaneurysm), with a mean neck length 19.7 ± 6.6 mm that were treated with multiple hybrid and endovascular techniques were included. A total of 329 EndoAnchors were used with a mean of 6.1 ± 2.5 per patient. Overall adequate AWP was 86%, whereas arch (Ishimaru's zones 0-2) deployments achieved 80.6% when compared to 87.3% in descending thoracic aorta (dTA); although there was no statistical significance. Freedom from type I endoleaks was 88% at 2 year follow-up, due to 4 type IA endoleaks, two of them successfully treated, one with conservative treatment due to complexity of repair and remaining patient died 1 year later due to endograft infection. There were reported five EndoAnchor-related issues; four losses and one renal stent-graft was crushed due to catheter deflection solved with balloon reinflation. None of the losses had clinical significance. Overall mortality is described for 7 (9.5%) patients, one of them aneurysm-related.

CONCLUSIONS

The adjunctive use of EndoAnchors in TEVAR and complex TEVAR procedures achieved acceptable outcomes at midterm in a high-risk series with hostile seal zones. Still, they should be still judiciously used as there is lack of data to suggest a more liberal use; therefore, the landing zone should not be compromised in favour of their use.

Для цитирования: Reyes Valdivia Andrés, Milner Ross, Heijmen Robin, Riambau Vicente, Rousseau Hervé, Tinelli Giovanni, Kotelis Drosos, Zanabili Al-Sibbai Ahmad A, Pitoulias Georgios, Zúñiga Claudio Gandarias, de Beaufort Hector W L, Panagiotis Doukas, Chaudhuri Arindam. Mid-term outcomes of the use of endoanchors during thoracic endovascular aortic repair in multicentre analysis.. Vascular. 2022. DOI: 10.1177/17085381221076320.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.